Search Results - "Adhikari, Rishav"

National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 by Adhikari, Rishav, Jha, Kunal, Dardari, Zeina, Heyward, James, Blumenthal, Roger S, Eckel, Robert H, Alexander, G Caleb, Blaha, Michael J

“…Background Sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) mitigate cardiovascular risk in…”
Get full text

Mechanical characterization of recycled concrete under various aggregate replacement scenarios by Sajan, K.C., Adhikari, Rishav, Mandal, Bharat, Gautam, Dipendra

“…Due to limited availability of concrete sources, recycled concrete is gaining more attention. Virtually all studies on recycled concrete have focused on…”
Get full text

Online searches for hepatocellular carcinoma drugs mirror prescription trends across specialties and changes in guideline recommendations by Berning, Philipp, Schroer, Adrian E, Adhikari, Rishav, Razavi, Alexander C, Cornelis, Francois H, Erinjeri, Joseph P, Solomon, Stephen B, Sarkar, Debkumar, Vargas, Hebert Alberto, Schöder, Heiko, Fox, Josef J, Dzaye, Omar

“…The treatment options for systemically progressed hepatocellular carcinoma (HCC) have significantly expanded in recent years. In this study, we aimed to…”
Get full text

Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study by Dzaye, Omar, Berning, Philipp, Razavi, Alexander C, Adhikari, Rishav, Jha, Kunal, Nasir, Khurram, Ayers, John W, Mortensen, Martin Bødtker, Blaha, Michael J

“…Several clinical trials have demonstrated that many SGLT-2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP-1 RA) can reduce the risk of cardiovascular…”
Get full text

USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS BY CARDIOLOGISTS SINCE THE RELEASE OF 2022 AHA/ACC/HFSA GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE by Grandhi, Gowtham R., Adhikari, Rishav, Tasdighi, Erfan, Osei, Albert D., Khorsandi, Michael, Mehta, Anurag, Blaha, Michael

“…Heart Failure Several studies have shown that most patients who are eligible for an Sodium-glucose Cotransporter-2 inhibitor (SGLT2i) are not receiving them…”
Get full text

COMPARING PRESCRIPTION TRENDS FOR ORAL AND SUBCUTANEOUS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RA) IN THE UNITED STATES by Adhikari, Rishav, Grandhi, Gowtham, Blaha, Michael J.

Get full text

Abstract P514: Evaluating the Concordance Between Trends in Prescription Volume and Online Interest for the Weight Loss Formulation of Semaglutide by Adhikari, Rishav, Dzaye, Omar, Blaha, Michael J

“…IntroductionWeight loss dosing of semaglutide (Wegovy™) is a preferred anti-obesity medication due to its efficacy, safety, and potential cardioprotective…”
Get full text

Nephrologist Use of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Relative to Other Specialties, 2015-2022: FR-PO902 by Adhikari, Rishav, Jha, Kunal, Blaha, Michael J.

Get full text

THE UNTAPPED POTENTIAL OF COLCHICINE IN CARDIOVASCULAR PREVENTION by Mhaimeed, Omar, Khorsandi, Michael, Adhikari, Rishav, Blaha, Michael J.

Get full text

CARDIOLOGIST USE OF SGLT2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS SINCE RELEASE OF FAVORABLE CARDIOVASCULAR OUTCOMES TRIALS: A NATIONAL STUDY by Adhikari, Rishav, Heyward, James, Alexander, G. Caleb, Blaha, Michael

Get full text

LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics by Tasdighi, Erfan, Adhikari, Rishav, Almaadawy, Omar, Leucker, Thorsten M, Blaha, Michael J

“…Lipoprotein(a) [Lp(a)] is a molecule bound to apolipoprotein(a) with some similarity to low-density lipoprotein cholesterol (LDL-C), which has been found to be…”
Get full text

Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use by Soroosh, Garshasb P., Tasdighi, Erfan, Adhikari, Rishav, Blaha, Michael J.

“…Personalizing risk assessment and treatment decisions for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) rely on pooled cohort…”
Get full text

Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes by Jha, Kunal K., Adhikari, Rishav, Tasdighi, Erfan, Osuji, Ngozi, Rajan, Tanuja, Blaha, Michael J.

“…  Purpose of Review This forward-looking review summarizes existing evidence from cardiovascular outcome trials on cardiometabolic risk-reduction in type 2…”
Get full text

Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium by Boakye, Ellen, Grandhi, Gowtham R., Dardari, Zeina, Adhikari, Rishav, Soroosh, Garshasb, Jha, Kunal, Dzaye, Omar, Tasdighi, Erfan, Erhabor, John, Kumar, Sant J., Whelton, Seamus, Blumenthal, Roger S., Albert, Michael, Rozanski, Alan, Berman, Daniel S., Budoff, Matthew J., Miedema, Michael D., Nasir, Khurram, Rumberger, John A., Shaw, Leslee J., Blaha, Michael

“…Objective The effectiveness of coronary artery calcification (CAC) for risk stratification in obesity, in which imaging is often limited because of a reduced…”
Get full text

Suitability Assessment of Stone Columns to Improve Soil Foundation in Kathmandu Valley, Nepal by Bhochhibhoya, Sanish, Maharjan, Roisha, Adhikari, Rishav, Gurung, Sagar, Adhikari, Purushottam, Shrestha, Saman, K. C., Madhu Sudan

“…Kathmandu Valley consists of a dynamic subsoil profile, so utilizing an effective method like stone columns to mitigate any forthcoming geotechnical problems…”
Get full text

Abstract P269: Sodium Transporter Profile in Mice Lacking AT1A Receptors in the Renal Proximal Tubule by McDonough, Alicia A, Izuhara, Audrey K, Xiang, Zhidan, Ralph, Donna L, Adhikari, Rishav, Gurley, Susan B

“…Abstract only We have reported that mice lacking AT1A receptors (KO) in renal proximal tubule (PT) have 10 mmHg lower baseline BP and less PT fluid…”
Get full text

Nitrogen recovery via aquaponics in Nepal: current status, prospects, and challenges by Adhikari, Rishav, Rauniyar, Sriyanka, Pokhrel, Nishan, Wagle, Amrita, Komai, Takeshi, Paudel, Shukra Raj

“…Aquaponics is a bio-integrated system that couples recirculating aquaculture with hydroponics. Existing aquaculture has been a continuous source of…”
Get full text

Potential nitrous oxide (N2O) emission from aquaculture in Nepal by Paudel, Shukra Raj, Luitel, Saujan, Adhikari, Rishav, Wagle, Amrita, You, Kwangtae

“…Nitrous oxide has a greenhouse potential 310 times that of carbon dioxide (CO 2 ) over a 100-year lifespan. N 2 O has been produced in the aquaculture system…”
Get full text

Vascular control of kidney epithelial transporters by Sparks, Matthew A, Dilmen, Emre, Ralph, Donna L, Rianto, Fitra, Hoang, Thien A, Hollis, Alison, Diaz, Edward J, Adhikari, Rishav, Chew, Gabriel, Petretto, Enrico G, Gurley, Susan B, McDonough, Alicia A, Coffman, Thomas M

“…A major pathway in hypertension pathogenesis involves direct activation of ANG II type 1 (AT ) receptors in the kidney, stimulating Na reabsorption. AT…”
Get more information

Abstract P315: Vascular AT1 Angiotensin Receptors Do Not Contribute to Albuminuria or Hyperfiltration in Diabetes by Sparks, Matthew A, Johnson, Stacy, Adhikari, Rishav, Diaz, Edward, Kupin, Aaron, Bendt, Kat, Gurley, Susan, Coffman, Thomas

“…Abstract only Blockade of the renin angiotensin system (RAS) reduces albuminuria, attenuates hyperfiltration, and slows the progression of diabetic nephropathy…”
Get full text